File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Enhanced liver fibrosis score stratifies hepatocellular carcinoma risk in patients with hepatitis B surface antigen seroclearance

TitleEnhanced liver fibrosis score stratifies hepatocellular carcinoma risk in patients with hepatitis B surface antigen seroclearance
Authors
Mak, LYCheung, KSMHui, WHRWong, DKHFung, JYuen, RMFSeto, WKW
Issue Date2022
Citation
Clinical Infectious Diseases, 2022 How to Cite?
DOI: http://dx.doi.org/10.1093/cid/ciac387
AbstractIn this prospective study involving 337 chronic hepatitis B patients who achieved spontaneous HBsAg seroclearance (SC), serum Enhanced Liver Fibrosis (ELF) before SC was associated with hepatocellular carcinoma (HCC) (hazard ratio 2.588), and ELF <10.8 was associated with >97% reduction in risk of HCC development in patients with ageSC≥50 (n = 190).
Persistent Identifierhttp://hdl.handle.net/10722/313800
ISI Accession Number ID
WOS:000819456700001

 

DC FieldValueLanguage
dc.contributor.authorMak, LY-
dc.contributor.authorCheung, KSM-
dc.contributor.authorHui, WHR-
dc.contributor.authorWong, DKH-
dc.contributor.authorFung, J-
dc.contributor.authorYuen, RMF-
dc.contributor.authorSeto, WKW-
dc.date.accessioned2022-07-05T05:05:57Z-
dc.date.available2022-07-05T05:05:57Z-
dc.date.issued2022-
dc.identifier.citationClinical Infectious Diseases, 2022-
dc.identifier.urihttp://hdl.handle.net/10722/313800-
dc.description.abstractIn this prospective study involving 337 chronic hepatitis B patients who achieved spontaneous HBsAg seroclearance (SC), serum Enhanced Liver Fibrosis (ELF) before SC was associated with hepatocellular carcinoma (HCC) (hazard ratio 2.588), and ELF <10.8 was associated with >97% reduction in risk of HCC development in patients with ageSC≥50 (n = 190).-
dc.languageeng-
dc.relation.ispartofClinical Infectious Diseases-
dc.titleEnhanced liver fibrosis score stratifies hepatocellular carcinoma risk in patients with hepatitis B surface antigen seroclearance-
dc.typeArticle-
dc.identifier.emailMak, LY: lungyi@hku.hk-
dc.identifier.emailCheung, KSM: cks634@hku.hk-
dc.identifier.emailHui, WHR: huirex@connect.hku.hk-
dc.identifier.emailWong, DKH: danywong@hku.hk-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.emailSeto, WKW: wkseto@hku.hk-
dc.identifier.authorityMak, LY=rp02668-
dc.identifier.authorityCheung, KSM=rp02532-
dc.identifier.authorityWong, DKH=rp00492-
dc.identifier.authorityYuen, RMF=rp00479-
dc.identifier.authoritySeto, WKW=rp01659-
dc.identifier.doi10.1093/cid/ciac387-
dc.identifier.hkuros333998-
dc.identifier.isiWOS:000819456700001-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats